Histopathologic Diagnostic Agreement Study in Bone and Soft Tissue Tumors: The SELNET Sarcoma Network Experience

A diagnostic agreement of 85.3% was obtained between the original diagnosis in each country of the SELNET consortium and the expert pathologist of the network. Morphologic assessment of tumors, the use of newer immunohistochemical markers, and molecular analysis on a limited number of cases were found to be useful in correcting discrepancies.

Authors

Institutions

Publication Details

Journal
JCO Global Oncology
Published
2025-12-01
DOI
https://doi.org/10.1200/go-25-00394
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Histopathologic Diagnostic Agreement Study in Bone and Soft Tissue Tumors: The SELNET Sarcoma Network Experience

Antonio M. Gutierrez, Lucia Gonzalez, Rafael Yus Ramos, David S. Moura et al.
JCO Global Oncology
Sarcoma Diagnosis and Treatment
article

Histopathologic Diagnostic Agreement Study in Bone and Soft Tissue Tumors: The SELNET Sarcoma Network Experience

Antonio M. Gutierrez, Lucia Gonzalez, Rafael Yus Ramos, David S. Moura, Alberto Righi, J.C. Haro Varas, Nadia Hindi, Marina Pacheco, María Ofelia Cabrejas Acuña, María Luisa Cabañas, Javier Martín‐Broto, Angelo Paolo Dei Tos, R. Badilla, Felipe D’Almeida Costa, Carmen Nieves Hernández-León, Matías Chacón, Paola Collini, Jean‐Yves Blay, Haydee Caro, Cleofé Romagosa, Salvatore Provenzano, Luis Matamala, Sandro Casavilca‐Zambrano, N. V. Jiménez, Bruna Bianca Lopes David, Marta Sbaraglia, Victor Castro Oliden, Marco Gambarotti, Nicolás Devaud, Gisela German, María Lucila González Donna, Felipe Buscaglia, Fernando Augusto Batista Campos, R.A Villarreal Guzmán, J Merino, Efraı́n Mercado, Ronald Limon, Gema Aguil, Gabriela Chaves Quesada, Teresa Fili
article en

Abstract

A diagnostic agreement of 85.3% was obtained between the original diagnosis in each country of the SELNET consortium and the expert pathologist of the network. Morphologic assessment of tumors, the use of newer immunohistochemical markers, and molecular analysis on a limited number of cases were found to be useful in correcting discrepancies.

JCO Global OncologyVol. 11(11)
Universitat Autònoma de Barcelona (ES), University of Padua (IT), Rafael Advanced Defense Systems (Israel) (IL), Instituto Cajal (ES), Hospital Universitario de Canarias (ES), AC Camargo Hospital (BR), Universidad de Costa Rica (CR), Centre Léon Bérard (FR), Hospital São Vicente (BR), Istituto Ortopedico Rizzoli (IT), Instituto Nacional de Enfermedades Neoplásicas (PE), Hospital San Juan de Dios (CL), Instituto Alexander Fleming (AR), Vall d'Hebron Hospital Universitari (ES), Hospital Universitario Fundación Jiménez Díaz (ES), Fundación para la Investigación, Docencia y Prevención del Cáncer (AR), Servicio Diabetología Hospital Córdoba (AR), Fundación Arturo López Pérez (CL), Instituto Nacional de Câncer - INCA (BR), Instituto Nacional del Cáncer (CL), Hospital Universitario Son Espases (ES), Sociedade Brasileira de Oncologia Clínica (BR), Hospital del Niño (PA), Instituto Nacional de Cancerología (MX), Universidad Nacional del Oriente (BO), Fondazione IRCCS Istituto Nazionale dei Tumori (IT), Centro de Investigación Biomédica en Red de Cáncer (ES), Universidad Autónoma de Madrid (ES)
Openalex Percentile: Top 41%
Sarcoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.